EXCLUSIVE: Was This the Plan? Chinese Officials Applied for Patent on Remdesivir to Treat Coronavirus Soon After Virus Spread in Hubei Province

The deadly China coronavirus that started in China sometime in late 2019 has now circled the globe.  Evidence suggests that the coronavirus didn’t come naturally.  We still don’t know whether the deadly virus was leaked intentionally or if it was an accident.

But we do know that the Chines edid attempt to market a cure for the coronavirus to the world in January after the virus began to spread.

In late March FOX News host Tucker Carlson reported on a CHINESE study in the Western press on the origin of the novel coronavirus.  The study concluded the deadly virus came out of local laboratories in Hubei Province. The smoking gun in the study is the viral link to horseshoe bats which are not sold in local wet markets and are not native to Wuhan. In fact the closest colony is 900 kilometers away. There is no evidence horseshoe bats were sold in the Wuhan wet markets. The local labs used this bat specimen and the virus likely came from a lab in Wuhan.

According to the report from Wuhan the coronavirus came from either the Wuhan Center for Disease Control and Prevention or Wuhan Institute of Virology in Wuhan, China.

These reports linking bats to the coronavirus started making the rounds back in January. A research paper published in the Wuhan Centre for Disease Control and Prevention determined the source of the coronavirus is a laboratory near the Seafood Market in Wuhan.

On Monday The Gateway Pundit reported that the China coronavirus has connections to former leader of the Chinese Communist Party, Jiang Zemin. For starters, Jiang is the grandfather of Jiang Zhicheng,  who has a controlling interest in WuXi AppTec, which controls Fosun Pharma.

Chart via  Yaacov Apelbaum

In January of this year, weeks after the coronavirus was first reported in China, the Wuhan Institute of Virology applied for a patent on a US drug, Remdesivir, used to treat coronavirus infections.

Remdesivir is used for the treatment of Ebola and coronavirus infections.  The drug showed early success in Washington state treating the coronavirus outbreak near Seattle.

Soros Fund Management invested in WuXi in 2011.  The Gateway Pundit reported on Soros’s investments in WuXi AppTec a few weeks ago.

This is a startling development.
After the coronavirus leaked out in the city of Wuhan in Hubei Province, the Chinese attempted to make money by applying for the patent on the drug remdesivir used to treat the deadly virus.
Was the coronavirus leaked by accident or was it intentional?  Will we ever know?

Hat tip Yaacov Apelbaum and D. Manny

 

Dear Reader - The enemies of freedom are choking off the Gateway Pundit from the resources we need to bring you the truth. Since many asked for it, we now have a way for you to support The Gateway Pundit directly - and get ad-reduced access. Plus, there are goodies like a special Gateway Pundit coffee mug for supporters at a higher level. You can see all the options by clicking here - thank you for your support!
Photo of author
Joe Hoft is a Radio Host at TNTRadio.live, Author, Former International Corporate Executive in Hong Kong for a Decade, and a Contributor at TGP since 2016. Joe is the author of five books, including his new bestseller, "The Steal: Volume II - The Impossible Occurs" which addresses the stolen 2020 Election and provides an inventory of issues that prove that the 2020 Election was uncertifiable and never should have been certified for Joe Biden.

You can email Joe Hoft here, and read more of Joe Hoft's articles here.

 

Thanks for sharing!